Morphine Sulfate in 5% Dextrose Injection recalled over sterility concerns
- Recall date
- November 12, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SterRx, LLC recalls Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburg…
- Recall number
- D-0313-2022
- FDA classification
- Class II
- Brand / firm
- SterRx, LLC
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-452-01.
Get recall alerts
Free email alert whenever SterRx, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SterRx, LLC